Irbesartan-Mepha 150 mg
Irbesartan-Mepha 150 mg is a medicine authorised by Swissmedic under authorisation number 61511. The authorisation holder is Mepha Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 09 February 2011 and the authorisation is valid without a time limit. ATC code C09CA04 places the medicine in the group Agents acting on the renin-angiotensin system.
| Authorisation number | 61511 |
|---|---|
| Name | Irbesartan-Mepha 150 mg |
| Full name | Irbesartan-Mepha 150 mg, Filmtabletten |
| Authorisation holder | Mepha Pharma AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | C09CA04 |
| First authorisation | 09 February 2011 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Irbesartan-Mepha 150 mg, Filmtabletten | B | 09 February 2011 |
| 2 | Irbesartan-Mepha 300 mg, Filmtabletten | B | 09 February 2011 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 28 | Tablette(n) | C09CA04 | 02.07.1. | B |
| 2 | 98 | Tablette(n) | C09CA04 | 02.07.1. | B |
| 3 | 28 | Tablette(n) | C09CA04 | 02.07.1. | B |
| 4 | 98 | Tablette(n) | C09CA04 | 02.07.1. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Irbesartan-Mepha 150 mg authorised in Switzerland?
Yes. Irbesartan-Mepha 150 mg is authorised by Swissmedic under authorisation number 61511, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Irbesartan-Mepha 150 mg have?
Irbesartan-Mepha 150 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Irbesartan-Mepha 150 mg?
The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.